Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Preoperative staging and outcome following surgical and local resection of T1 colorectal cancer

Nilsson, Emelie LU (2026) In Lund University, Faculty of Medicine Doctoral Dissertation Series
Abstract
Background: There are two conceptually different surgical treatment options for patients with T1 colorectal cancer (CRC): radical surgical resection and local resection. In addition, adjuvant chemotherapy is recommended in cases with lymph node metastases. However, surgical overtreatment of early CRC is a concern and may be related to limitations in preoperative work-up as well as tumour risk classification. In addition, patients with node-positive T1 CRC disease may be undertreated with respect to adjuvant chemotherapy.

Aims: Study I: To assess the accuracy of MRI-based staging in early rectal cancer (RC). Study II: Compare recurrence after endoscopic and surgical resection across risk groups in pT1 colon cancer (CC) and identify... (More)
Background: There are two conceptually different surgical treatment options for patients with T1 colorectal cancer (CRC): radical surgical resection and local resection. In addition, adjuvant chemotherapy is recommended in cases with lymph node metastases. However, surgical overtreatment of early CRC is a concern and may be related to limitations in preoperative work-up as well as tumour risk classification. In addition, patients with node-positive T1 CRC disease may be undertreated with respect to adjuvant chemotherapy.

Aims: Study I: To assess the accuracy of MRI-based staging in early rectal cancer (RC). Study II: Compare recurrence after endoscopic and surgical resection across risk groups in pT1 colon cancer (CC) and identify risk factors for recurrence. Study III: Compare recurrence after transanal endoscopic microsurgery (TEM) and surgical resection across risk groups in pT1 RC. Study IV: Investigate the effect of adjuvant chemotherapy on recurrence and survival in pT1 node-positive (T1N+) CRC and identify factors associated with not receiving adjuvant chemotherapy.
Methods: The four studies were retrospective cohort studies based on prospectively collected data derived from the Swedish Colorectal Cancer Registry. Study I, patients with RC staged as cT1–2 RC or pT1 (2009–2018), Study II patients with pT1 CC (2009– march 2021), Study III patients with pT1 RC (2009–2022), Study IV pT1 N+ CRC (2009–2022). Neoadjuvant treatment was a general exclusion criterion for all studies.

Results and conclusions: Study I. MRI plays a pivotal role in the work-up of RC. However, MRI was insufficiently accurate for both T and N staging in early RC, with a risk of both over- and understaging. Based on these findings, MRI should not be used as the sole modality to determine eligibility for local resection. Study II. Recurrence rates after pT1 CC were low and comparable following endoscopic and surgical resection, even in patients with high-risk tumours. Lymphovascular invasion (LVI) was identified as a strong risk factor for recurrence. Further studies to identify pT1 CC patients with poor prognosis who may benefit from additional treatment are warranted. Study III. In contrast, local recurrence rates following TEM were significantly higher than those after surgical resection, even in patients with low-risk tumours, calling into question the role of TEM as a curative treatment option. Study IV. Adjuvant chemotherapy was associated with substantially improved disease-free and overall survival in patients with pT1N+ CRC, highlighting the importance of minimizing unfounded deviations from treatment guidelines. (Less)
Please use this url to cite or link to this publication:
author
supervisor
opponent
  • MD, Professor Myrelid, Pär, Division of Surgery, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping University Hospital.
organization
publishing date
type
Thesis
publication status
published
subject
keywords
colorectal cancer, early diagnosis, recurrence, surgical resection, local resection, adjuvant chemotherapy, risk factors for recurrence, overall survival, disease free survival
in
Lund University, Faculty of Medicine Doctoral Dissertation Series
issue
2026:31
pages
111 pages
publisher
Lund University, Faculty of Medicine
defense location
Kvinnoklinikens aula, Jan Waldenströms gata 47, Skånes Universitetssjukhus i Malmö
defense date
2026-03-06 09:00:00
ISSN
1652-8220
ISBN
978-91-8021-829-0
language
English
LU publication?
yes
id
c3b6ff35-e2c4-4505-932a-9a15c278d979
date added to LUP
2026-02-12 23:53:31
date last changed
2026-02-13 12:38:46
@phdthesis{c3b6ff35-e2c4-4505-932a-9a15c278d979,
  abstract     = {{Background: There are two conceptually different surgical treatment options for patients with T1 colorectal cancer (CRC): radical surgical resection and local resection. In addition, adjuvant chemotherapy is recommended in cases with lymph node metastases. However, surgical overtreatment of early CRC is a concern and may be related to limitations in preoperative work-up as well as tumour risk classification. In addition, patients with node-positive T1 CRC disease may be undertreated with respect to adjuvant chemotherapy.<br/><br/>Aims: Study I: To assess the accuracy of MRI-based staging in early rectal cancer (RC). Study II: Compare recurrence after endoscopic and surgical resection across risk groups in pT1 colon cancer (CC) and identify risk factors for recurrence. Study III: Compare recurrence after transanal endoscopic microsurgery (TEM) and surgical resection across risk groups in pT1 RC. Study IV: Investigate the effect of adjuvant chemotherapy on recurrence and survival in pT1 node-positive (T1N+) CRC and identify factors associated with not receiving adjuvant chemotherapy.<br/>Methods: The four studies were retrospective cohort studies based on prospectively collected data derived from the Swedish Colorectal Cancer Registry. Study I, patients with RC staged as cT1–2 RC or pT1 (2009–2018), Study II patients with pT1 CC (2009– march 2021), Study III patients with pT1 RC (2009–2022), Study IV pT1 N+ CRC (2009–2022). Neoadjuvant treatment was a general exclusion criterion for all studies.<br/><br/>Results and conclusions: Study I. MRI plays a pivotal role in the work-up of RC. However, MRI was insufficiently accurate for both T and N staging in early RC, with a risk of both over- and understaging. Based on these findings, MRI should not be used as the sole modality to determine eligibility for local resection. Study II. Recurrence rates after pT1 CC were low and comparable following endoscopic and surgical resection, even in patients with high-risk tumours. Lymphovascular invasion (LVI) was identified as a strong risk factor for recurrence. Further studies to identify pT1 CC patients with poor prognosis who may benefit from additional treatment are warranted. Study III. In contrast, local recurrence rates following TEM were significantly higher than those after surgical resection, even in patients with low-risk tumours, calling into question the role of TEM as a curative treatment option. Study IV. Adjuvant chemotherapy was associated with substantially improved disease-free and overall survival in patients with pT1N+ CRC, highlighting the importance of minimizing unfounded deviations from treatment guidelines.}},
  author       = {{Nilsson, Emelie}},
  isbn         = {{978-91-8021-829-0}},
  issn         = {{1652-8220}},
  keywords     = {{colorectal cancer; early diagnosis; recurrence; surgical resection; local resection; adjuvant chemotherapy; risk factors for recurrence; overall survival; disease free survival}},
  language     = {{eng}},
  number       = {{2026:31}},
  publisher    = {{Lund University, Faculty of Medicine}},
  school       = {{Lund University}},
  series       = {{Lund University, Faculty of Medicine Doctoral Dissertation Series}},
  title        = {{Preoperative staging and outcome following surgical and local resection of T1 colorectal cancer}},
  url          = {{https://lup.lub.lu.se/search/files/242190364/Avhandling_Emelie_Nilsson_LUCRIS.pdf}},
  year         = {{2026}},
}